Lisa-Marie Hinzmann Obstetrics, Gynaecology & Reproductive Medicine Specialist Timothy (Tim) Heath, MPH Wellness Manager, LiveWell Solutions Together, the panel explored how GLP-1 medications are reshaping conversations around obesity, preventative medicine, chronic disease management, hormonal health, and lifestyle change
Track cycles during treatment, communicate changes with your prescriber, and watch for patterns that warrant gynecologic evaluation
Short-acting drugs include exenatide twice daily, lixisenatide once daily and oral semaglutide once daily, while long-acting drugs include liraglutide, semaglutide, exenatide, albiglutide and dulaglutide all being administered once weekly
doi: 10.1016/j.cmet.2012.06.015 31 AlhadeffALBairdJ-PSwickJCHayesMRGrillHJ
2021;12:1321 Chen J, Ren H, Zhou P, Zheng S, Du B, Liu X, et al